Rapid Test Detects HIV-1 and HIV-2 Antibodies and HIV-1 Antigen

THURSDAY, Aug. 8 (HealthDay News) -- The first rapid test to detect the HIV-1 antigen, as well as blood antibodies for the HIV-1 and HIV-2 strains, has been approved by the U.S. Food and Drug Administration.

The Alere Determine HIV-1/2 Ag/Ab Combo test can detect these markers for the AIDS-causing virus in human serum, plasma and blood specimens, the agency said in a news release.

Detection of the HIV-1 antigen may allow doctors to diagnose the viral infection earlier than detection of the antibodies alone, the FDA said.

Some 50,000 people are infected with HIV each year in the United States, the agency said, citing statistics from the U.S. Centers for Disease Control and Prevention. Of the more than 1 million people living with HIV in the United States, about 20 percent haven't been diagnosed, the FDA added.

The new test is produced by Orgenics Ltd., whose parent, Alere Inc., is based in Yavne, Israel.

More information

The FDA has more about this approval.

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.